ADVFN Logo
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

TNXP Tonix Pharmaceuticals Holding Corporation

0.3199
0.0035 (1.11%)
시간외 거래
최종 업데이트: 07:53:42
15분 지연
기업명 주식 심볼 시장 주식 타입
Tonix Pharmaceuticals Holding Corporation TNXP 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0035 1.11% 0.3199 07:53:42
개장가 저가 고가 종가 전일 종가
0.3164 0.31 0.33 0.322 0.3164
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
23/02/202423:30GLOBENew to The Street Announces Line-up of its Corporate..
20/02/202422:00GLOBETonix Pharmaceuticals to Participate in the 2024 BIO CEO &..
16/02/202423:30GLOBENew to The Street Airs Episode 556 Featuring Five Corporate..
16/02/202407:02EDGAR2Form 8-K - Current report
15/02/202405:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202422:00GLOBETonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3..
13/02/202422:05EDGAR2Form 8-K - Current report
13/02/202422:00GLOBETonix Pharmaceuticals Announces Engagement of Rho as CRO to..
12/02/202422:00GLOBETonix Pharmaceuticals Announces FDA IND Clearance for DoD..
12/02/202421:06EDGAR2Form 8-K - Current report
31/01/202421:05EDGAR2Form 8-K - Current report
31/01/202421:00GLOBETonix Pharmaceuticals Announces Research Indicating..
29/01/202421:00EDGAR2Form 8-K - Current report
29/01/202421:00GLOBETonix Pharmaceuticals Announces Conditional Acceptance of..
26/01/202406:08EDGAR2Form 8-K - Current report
25/01/202421:00GLOBETonix Pharmaceuticals Announces KOL Webinar to Discuss..
20/01/202406:31EDGAR2Form 8-K - Current report
12/01/202406:53EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/01/202421:00GLOBETonix Pharmaceuticals Presents Additional Data Highlighting..
09/01/202407:07EDGAR2Form 8-K - Current report
09/01/202406:33EDGAR2Form DEF 14A - Other definitive proxy statements
04/01/202406:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/01/202421:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
03/01/202406:15EDGAR2Form 8-K - Current report
30/12/202307:04EDGAR2Form PRE 14A - Other preliminary proxy statements
27/12/202307:25EDGAR2Form DEF 14A - Other definitive proxy statements
22/12/202307:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/12/202307:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/12/202307:04EDGAR2Form 8-K - Current report
21/12/202300:35GLOBETonix Pharmaceuticals Announces Registered Direct Offering..
21/12/202300:31EDGAR2Form 8-K - Current report
21/12/202300:30GLOBETonix Pharmaceuticals Announces Highly Statistically..
12/12/202321:00EDGAR2Form 8-K - Current report
11/12/202321:00GLOBETonix Pharmaceuticals to Present at The National Academies..
09/12/202307:14EDGAR2Form 8-K - Current report
04/12/202321:10EDGAR2Form 8-K - Current report
04/12/202321:00GLOBETonix Pharmaceuticals Announces IND Clearance by the FDA for..
28/11/202321:00GLOBETonix Pharmaceuticals to Present at Two Upcoming Investor..
15/11/202321:05EDGAR2Form 8-K - Current report
15/11/202321:00GLOBETonix Pharmaceuticals Completes Clinical Stage of Phase 3..
13/11/202321:05EDGAR2Form 8-K - Current report
13/11/202321:00GLOBETonix Pharmaceuticals Announces Enrollment Initiated in Mass..
10/11/202306:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:15GLOBETonix Pharmaceuticals Reports Third Quarter 2023 Financial..
02/11/202321:05EDGAR2Form 8-K - Current report
02/11/202321:00GLOBETonix Pharmaceuticals’ Vaccine Candidate, TNX-1800, Selected..
01/11/202306:06EDGAR2Form 8-K - Current report
01/11/202306:00GLOBETonix Pharmaceuticals Announces Topline Results from Phase 2..
30/10/202320:49EDGAR2Form 8-K - Current report
30/10/202320:00GLOBETonix Pharmaceuticals Announces New Data Involving TNX-1500..

최근 히스토리

Delayed Upgrade Clock

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

도움 및 지원받기: kr-support@advfn.com